Based on its recent analysis of the North American battery analytics software-as-a-service (SaaS) market, Frost & Sullivan recognizes Voltaiq, Inc. with the 2021 North America Product Leadership Award for its easy-to-use Enterprise Battery Intelligence™ (EBI) platform. It is the only fully automated, end-to-end battery analytics solution capable of systematically gathering, analyzing, and generating actionable insights from vast quantities of battery data. These insights optimize its customers'
Frost & Sullivan (via Public) / Artiza Commended by Frost & Sullivan for Ensuring Reliable 5G Implementation with its Modular Testing Solution, DuoSIM-5G publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
The multi-seat solution Cinemo Play Anywhere revolutionizes the passenger's user experience LONDON, June 2, 2021 /PRNewswire/ Based on its recent analysis of the global automotive in-vehicle
It offers exceptional customer experiences by applying an open and flexible cloud technology through integrations and omnichannel strategies SAO PAULO, June 1,.
ViewMind Applauded by Frost & Sullivan for Its One-of-a-Kind Digital Biomarker Technology for Neurocognitive Disorders
The AI-powered technology can enable early screening at scale for a range of neurocognitive conditions, such as Alzheimer s and mild cognitive impairment
SANTA CLARA, Calif., May 25, 2021 /PRNewswire/ Based on its recent analysis of the global market for digital biomarkers for neurocognitive disorders, Frost & Sullivan recognizes ViewMind with the 2021 Global Enabling Technology Leadership Award. ViewMind s reliable, non-invasive, affordable, and accessible digital biomarker technology employs artificial intelligence (AI) to deliver accurate clinical results. The solution offers a standardized, non-invasive test that can detect the onset of diseases, such as Alzheimer s, up to an incredible 20 years before clinical symptoms appear. By enabling early treatment, this state-of-the-art technology is revolutionizing the digital biomarkers market.